EUVIMEDOpdag EUVIMED
Open access

Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes

Bonnie Huang, Kristoffer Haurum Johansen, Pamela L Schwartzberg

Current Protocols in Immunology · 2019-02 · 124 (1)

DOI: 10.1002/cpim.62 ↗

At a glance

Journal article in Current Protocols in Immunology, published online on 2018-10-12. Written by Bonnie Huang and 2 co-authors. Institution: Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland. Major MEDLINE topics: Mutagenesis. Cited 27 times so far (Crossref); 72 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust, Intramural NIH HHS, National Human Genome Research Institute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The ability to alter gene expression directly in T lymphocytes has provided a powerful tool for understanding T cell biology, signaling, and function. Manipulation of T cell clones and primary T cells has been accomplished primarily through overexpression or gene‐silencing studies using cDNAs or shRNAs, respectively, which are often delivered by retroviral or lentiviral transduction or direct transfection methods. The recent development of CRISPR/Cas9‐based mutagenesis has revolutionized genomic editing, allowing unprecedented genetic manipulation of many cell types with greater precision and ease. This article outlines a protocol for CRISPR/Cas9‐mediated mutagenesis in primary T lymphocytes from Cas9 transgenic mice using retroviral delivery of guide RNAs. © 2018 by John Wiley & Sons, Inc.

Subjects

MeSH terms (MEDLINE)

MutagenesisAnimalsCRISPR-Cas SystemsCells, CulturedMiceMice, TransgenicT-Lymphocytes

Author keywords

CRISPRCas9gene knockoutmurine T cellsretroviral vector

Authors and institutions

  • Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
  • Genetic Disease Research Branch, National Human Genome Research Institute, Bethesda, Maryland.

Funding

  • Wellcome Trust
  • Intramural NIH HHS
  • National Human Genome Research Institute
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Cite

APA

Huang, B., Johansen, K. H., & Schwartzberg, P. L. (2019). Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes. Current Protocols in Immunology, 124(1). https://doi.org/10.1002/cpim.62

Vancouver

Huang B, Johansen KH, Schwartzberg PL. Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes. Current Protocols in Immunology. 2019;124(1). doi:10.1002/cpim.62

BibTeX
@article{Huang2019,
  author = {Huang, Bonnie and Johansen, Kristoffer Haurum and Schwartzberg, Pamela L},
  title = {Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes},
  journal = {Current Protocols in Immunology},
  year = {2019},
  volume = {124},
  number = {1},
  doi = {10.1002/cpim.62}
}
Start for free →